Coronary Stent Market Size, Share, Trends Analysis | Global | 2021 – 2027 | MedCore | Segmented by: Type (Bare-Metal Stents, Drug-Eluting Stents)
- Year: 2021
- Scope: 10 Years
- Region: Global
- Type: MedCore
The global coronary stents market size is estimated to increase over the forecast period to reach more than $6.6 billion in 2027.
The majority of the global coronary stents market share was controlled by Boston Scientific, Medtronic and Abbott. Overall, this global market research includes an analysis of coronary stents companies spawning across more than 70 countries in the world.
Coronary Stents Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Coronary Stents Procedure Volumes
- Market Drivers & Limiters for Each Market Segment
- Market Forecasts Until 2027, and Historical Data to 2017
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Coronary Stents Procedure Volumes
Through this study on the global coronary stents market, iData Research has performed an analysis on the procedure volumes in order to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.
Coronary Stents Market Insights
The largest market for coronary stents was the Asia Pacific region. Unit sales growth for the total coronary stent market is highly correlated with the annual PCI procedure volume and any significant changes will have a direct effect on sales volume. In addition, systemic healthcare reforms, increased access to healthcare and increasing disposable income in this region are all expected to positively affect the market.
Overall, the global market size for coronary stents market is expected to grow over the forecast period. The ASP of the coronary stent market is heavily weighted towards the dominant DES segment, which accounted for the majority of the units sold. ASP depreciation across all segments will be driven by bundling and competitive pricing pressure. Prices are expected to continue declining over the forecast period.
Coronary Stents Market Share Insights
In 2020, the global coronary stents market was controlled by three key competitors – Boston Scientific, Medtronic and Abbott.
Boston Scientific is the leading competitor in the global coronary stent market. Most of the company’s success can be attributed to its strong position in the DES market, where it held the leading share. The company currently offers the PREMIER™ and SYNERGY™ DES product lines, as well as the REBEL™ BMS product line. SYNERGY™ is the first and only FDA-approved DES with abluminal bioabsorbable polymer coating available in the U.S. market. REBEL™ is made of platinum chromium alloy, which is designed to reduce device usage, procedure times and radiation exposure.
Research Regional Coverage
Throughout this research series, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Contact Us For Additional Information
For full segmentation and any questions regarding research coverage, please contact us or send a request by pressing one of the buttons on the right.
- AngioDynamics
- Becton Dickinson
- Cook Medical
- Deltamed
- Medcomp
- Teleflex Medical
- Vygon
- And More
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Coronary Stent Market Size, Share, Trends Analysis | Global | 2021 – 2027 | MedCore | Segmented by: Type (Bare-Metal Stents, Drug-Eluting Stents)
$295 – $8,995
- 2021
- 10 Years
- Global
- MedCore
Related Reports
